Filling and finishing is the final stage in the process of vaccine manufacturing and also the most vulnerable to experiencing congestion in production. There are a number of possible solutions for this issue: -Facilities producing influenza vaccine are likely to have excess capacity for manufacturing -Adding shifts -Companies with a lot of staff and resources are leading the way in building the filling capacity for COVID vaccines -14 DCVMN members with excess capacity and resources have expressed their capabilities and willingness to tackle surge manufacturing or filling. - --Many members have available resources for formulation and fill-finish. -Fixing holes in the supply chain